HIRVELA; Leena

Patent Applications and Registrations

Patent applications and USPTO patent grants for HIRVELA; Leena.The latest application filed is for "therapeutically active steroidal derivatives".

Company Profile

0.7.9

HIRVELA; Leena - Oulu FI
HIRVELA; Leena - Turku FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutically Active Steroidal Derivatives App 20220127303 - HIRVELA; Leena ; et al.	2022-04-28
Therapeutically active steroidal derivatives Grant 11,254,703 - Hirvela , et al. February 22, 2	2022-02-22
Estra-1,3,5(10)-triene Compounds Condensed In Position 16(17) With A Pyrazole Ring As Inhibitors Of 17-hsd1 App 20220041647 - HIRVELA; Leena ; et al.	2022-02-10
Therapeutically Active Steroidal Derivatives App 20200317718 - HIRVELA; Leena ; et al.	2020-10-08
Therapeutically active steroidal derivatives Grant 10,717,761 - Hirvela , et al.	2020-07-21
Prodrugs of 17.beta.-HSD1-inhibitors Grant 10,626,140 - Hirvela , et al.	2020-04-21
Prodrugs of 17.BETA.-HSD1-inhibitors Grant 10,413,557 - Hirvela , et al. Sept	2019-09-17
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 Grant 10,377,791 - Eloranta , et al. A	2019-08-13
Therapeutically Active Steroidal Derivatives App 20180354984 - HIRVELA; Leena ; et al.	2018-12-13
Prodrugs Of 17.beta.-hsd1-inhibitors App 20180265541 - HIRVELA; Leena ; et al.	2018-09-20
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 Grant 9,850,272 - Hirvela , et al. December 26, 2	2017-12-26
Prodrugs of 17.BETA.-HSD1-inhibitors App 20170354664 - HIRVELA; Leena ; et al.	2017-12-14
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase Grant 9,663,549 - Eloranta , et al. May 30, 2	2017-05-30
Therapeutically Active Estratrienthiazole Derivatives As Hinibitors Of 17 B-hydroxysteroid Dehydrogenase, Type 1 App 20170114090 - ELORANTA; Maire ; et al.	2017-04-27
Therapeutically Active Estratrienthiazole Derivatives As Inhibitors Of 17.beta-hydroxy-steroid Dehydrogenase, Type 1 App 20170081356 - HIRVELA; Leena ; et al.	2017-03-23
Therapeutically Active 17-nitrogen Substituted Estratreinthiazole Derivatives As Inhibitors Of 17.beta-hydroxysteroid Dehydrogenase App 20170081357 - ELORANTA; Maire ; et al.	2017-03-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.